Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
1,071.64
-4.84 (-0.45%)
Official Closing Price
Updated: 7:00 PM EST, Dec 23, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,108,563
Open
1,063.50
Bid (Size)
1,070.51 (40)
Ask (Size)
1,073.00 (80)
Prev. Close
1,076.48
Today's Range
1,063.50 - 1,088.48
52wk Range
623.78 - 1,111.99
Shares Outstanding
956,580,893
Dividend Yield
0.56%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Novo Nordisk Stock Soars as "Wegovy Pill" Gains FDA Approval, Reshaping Obesity Market
Today 17:07 EST
Shares of Novo Nordisk (NYSE: NVO) surged more than 8% in early trading on December 23, 2025, after the pharmaceutical giant secured a landmark FDA approval for its high-dose oral semaglutide, branded...
Via
MarketMinute
Resilient Prosperity: Blowout Q3 GDP Growth Ignites Year-End Market Surge Amid 'No-Landing' Fears
Today 17:05 EST
The United States economy defied gravity in the third quarter of 2025, posting a staggering 4.3% annualized growth rate that has sent shockwaves through global financial markets. Released on December...
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Performance
YTD
+37.7%
+37.7%
1 Month
+0.1%
+0.1%
3 Month
+43.5%
+43.5%
6 Month
+37.7%
+37.7%
1 Year
+34.6%
+34.6%
More News
Read More
Stock Market Today, Dec. 23: Novo Nordisk Surges After FDA Approves Oral Wegovy Weight Loss Pill
↗
Today 17:02 EST
Via
The Motley Fool
Topics
Stocks
Novo Nordisk’s Worst Year In Over Four Decades May Be Ending — Thanks To A Weight-Loss Pill
↗
Today 8:14 EST
Via
Stocktwits
Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk
↗
Today 14:15 EST
Via
Stocktwits
Topics
Government
The Next Big Buyout? Abivax Emerges as a Premier M&A Contender for 2026 Amidst Biotech Consolidation Wave
Today 14:13 EST
Via
MarketMinute
Topics
Intellectual Property
Novo Nordisk Breaks the Mold: Oral Obesity Breakthrough Sends Shares to New Heights as Pharma Landscape Shifts
Today 14:05 EST
Via
MarketMinute
Topics
Economy
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus
↗
Today 14:04 EST
Via
Benzinga
Topics
ETFs
What's Going On With Eli Lilly Stock Today?
↗
Today 12:25 EST
Via
Benzinga
Thin Trading and High Hopes: Markets Eye a 'Santa Claus Rally' as 2025 Draws to a Close
Today 11:52 EST
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Santa Claus Rally Solidifies as S&P 500 Secures Third Consecutive Winning Session Amid Economic Resilience
Today 10:35 EST
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
The Great Biotech Rebound: How Pricing Clarity Rescued the Drug Sector in 2025
Today 10:17 EST
Via
MarketMinute
Topics
Economy
Eli Lilly Vs. Novo Nordisk: Which Stock Could Lead Pharma's 2026 Comeback
↗
Today 8:54 EST
Via
Benzinga
Nasdaq, S&P 500 Futures Tread Caution Ahead Of GDP, Confidence Data: Why NVO, ZIM, SIDU Are On Traders' Radar Today
↗
Today 4:25 EST
Via
Stocktwits
Topics
Stocks
3 Reasons Investors Love Eli Lilly (LLY)
December 22, 2025
Via
StockStory
Topics
Stocks
Why Abivax Stock Was on Fire Today
↗
December 22, 2025
Via
The Motley Fool
Novo Nordisk Jumps As FDA OKs Wegovy Pill As First-Ever Oral GLP-1 Weight Loss Drug
↗
December 22, 2025
Via
Investor's Business Daily
Novo Nordisk Stock Soars After Hours As FDA Greenlights Wegovy Pill For Weight Loss
↗
December 22, 2025
Via
Stocktwits
The Incretin Empire: Eli Lilly’s (LLY) Path to a $1 Trillion Market Cap and Beyond
December 22, 2025
Via
PredictStreet
Topics
Economy
Intellectual Property
The Pfizer Pivot: A Deep-Dive into PFE’s 2025 Financial Recovery and Strategic Rebirth
December 22, 2025
Via
PredictStreet
Topics
Economy
Intellectual Property
Eli Lilly - Momentum Near 52‑Week High As Trade Engine Flags Moderate Strength
↗
December 22, 2025
Via
Talk Markets
Should You Forget Novo Nordisk and Buy This Magnificent High-Yield Drug Stock Instead?
↗
December 22, 2025
Via
The Motley Fool
2 Profitable Stocks with Exciting Potential and 1 Facing Challenges
December 21, 2025
Via
StockStory
ELI LILLY & CO (NYSE:LLY) Combines Strong Earnings Momentum with Bullish Technical Setup
↗
December 20, 2025
Via
Chartmill
Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump
↗
December 19, 2025
Via
Investor's Business Daily
Topics
Government
Stocks
Frequently Asked Questions
Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 1,071.64
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 12/23/25 07:00 PM ET
What is the market capitalization of Eli Lilly?
The market capitalization of Eli Lilly is 1,025.11B
How many shares of Eli Lilly are outstanding?
Eli Lilly has 1,025B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.